Hemogenyx Pharmaceuticals Plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was GBP 4.32 million compared to GBP 1.13 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.467 GBX | +0.14% | -0.54% | -36.22% |
04-25 | Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | Hemogenyx Pharmaceuticals raises money for leukaemia treatment | AN |
1st Jan change | Capi. | |
---|---|---|
-36.22% | 25.13M | |
+17.08% | 123B | |
+13.29% | 107B | |
-6.05% | 24.01B | |
+1.95% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-12.25% | 16.23B | |
+1.67% | 13.43B | |
+22.57% | 11.32B |
- Stock Market
- Equities
- SILF Stock
- News Hemogenyx Pharmaceuticals Plc
- Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Half Year Ended June 30, 2023